OneSource powers second generic semaglutide nod in Canada
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings
Lifts full-year outlook as obesity drug boom accelerates
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
Subscribe To Our Newsletter & Stay Updated